StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3094% above fair value
$86.06−2.59 (-2.92%)

Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –

Solventum pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Solventum's pe ratio was 10.8× on Nov 11, 2026, against 9.8× a year earlier. Over the last 2 years it ranged from 7.4× to 34.9×, with a median of 11.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.8×+1.7
2025Dec 31, 20259.1×−6.8
2024Dec 31, 202415.9×–

More Solventum figures

See a number that looks wrong?